Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.
about
Anti-adenosine deaminase antibodies in lupus erythematosusCharacterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiencyPlasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient childBone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patientsPurine metabolism in lymphocytes from patients with primary hypogammaglobulinaemiaShort stature/short limb skeletal dysplasia with severe combined immunodeficiency and bowing of the femora: report of two patients and review.Spondylo-mesomelic-acrodysplasia with joint dislocations and severe combined immunodeficiency: a newly recognised immuno-osseous dysplasia.Expression of human adenosine deaminase after fusion of adenosine deaminase-deficient cells with mouse fibroblasts.Combined immunodeficiency and thymic abnormalities.Purine metabolism in adenosine deaminase deficiency.Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapyPurine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiencyCombined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia.Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral lymphocytes from patients with solid tumours.The Organogermanium Compound Ge-132 Interacts with Nucleic Acid Components and Inhibits the Catalysis of Adenosine Substrate by Adenosine Deaminase.Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.ATP depletion as a consequence of adenosine deaminase inhibition in man.Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.Radioimmunochemical quantitation of human adenosine deaminase.Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin.Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.Molecular cloning of the cDNA for a mutant mouse ribonucleotide reductase M1 that produces a dominant mutator phenotype in mammalian cells.New directions for the anti-retroviral chemotherapy of AIDS--a basis for a pharmacological approach to treatment.Enzymes of the purine metabolism: inhibition and therapeutic potential.Evaluating patients with suspected immunodeficiency. Guidelines for clinical and laboratory diagnosis.Two biochemical markers in lymphocyte subpopulations.Regional deficiency of secretory IgA in a patient with combined immunodeficiency of the ADA deficient type.Pegademase bovine: replacement therapy for severe combined immunodeficiency disease.Red cell adenosine deaminase (ADA) polymorphism in Southern Africa, with special reference to ADA deficiency among the !Kung.The metabolism of adenosine and distribution of adenosine receptor lymphocytes in two human circulating T cell subsets.Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?
P2860
Q24296971-9181D697-3334-433F-826B-59264F2306A3Q24561809-B40B7EDF-3D2B-4140-A222-6BEF5785AF8BQ28367646-F91B89EA-49BD-4F18-96ED-A63B920D4B65Q28367735-9563B83B-90C4-4ABC-9A6D-A9331A07A49AQ28972266-4C3CE0B3-2FED-4EF2-AECD-1CBFDB729617Q33596459-BC916FD3-04B3-4C19-856D-761ACA49D974Q33679624-243951F1-16E1-49BE-8756-797FCDC5C550Q33963095-F737752D-0212-4C8B-B32E-C030D638B179Q34860264-356A7BDB-A31B-4BED-92B0-717FDE0FBD5EQ35018224-BDCBBBD2-E4D7-4FEB-AC66-2DDFD06D1670Q35114440-DB0CF655-AE4C-42CD-84B5-24EFAB70C0A1Q35200011-B0157036-C651-4B90-A9BE-1D9AFA9E45D2Q35604784-9304E2CC-A58F-4764-90B6-1CA07115DF1DQ35714769-CF7EDE94-3463-4C9A-A267-6ADB0C910842Q35818107-1E9A1522-EDED-43AC-9BD9-F0346677DC6AQ35902514-13603630-AC3D-44A2-A74F-CF9356D61CFDQ35995727-532D4B6B-E70D-45DE-988C-86BF2E149B7FQ36044643-977FF071-CB27-459E-BB92-DD5A9EC76935Q36353064-F651BF0E-C04E-437C-A0C7-57CA7C1F3F47Q36359282-AD3E4535-D292-4A32-8435-1475FA485780Q36412113-60E308E3-8AF7-43B6-9015-D3A7E4E29F22Q37031935-C68E632C-30E3-46D6-A71B-046BD3DAA00BQ37041561-DDA1AE0A-05E1-41EF-8054-6C51DF729214Q37316593-92153AB0-FFC8-4AEE-99C4-2FFD894256C3Q37331491-DAA2A389-AC14-44AA-A7C8-599DC3B9B060Q38936385-AEF6A456-FAA7-45E8-BA48-29338FA3BC4BQ40650216-FEDF6526-38E9-4A05-824D-AC585A7AB3A8Q40710327-4D0440F1-7169-4CB1-BB2C-F2956BD47C6EQ40712361-B0D2555F-06E4-4668-998E-CCE9B44407BEQ41111764-CF44D516-0826-4A5B-A62C-5063AC66B7B2Q41516393-91CAFEAF-81D5-415E-9B1F-6F5A71249838Q41598372-E8165B02-7156-4509-857D-1F258982C4CFQ45881060-7670EB4B-924B-421D-AB78-FF3825B54B95Q46259633-F430F4DF-381A-49E1-899D-6B75222F0453Q54543447-8BB175D6-2E33-4339-8D2F-E4B2FA9482E3Q58736435-1A21B5B6-3382-4580-898B-14C3B47C4C2F
P2860
Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh-hant
name
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@en
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@nl
type
label
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@en
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@nl
prefLabel
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@en
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@nl
P2093
P1476
Combined immunodeficiency dise ...... ny, New York, October 1, 1973.
@en
P2093
Meuwissen HJ
Pickering RJ
P304
P356
10.1016/S0022-3476(75)80463-X
P407
P577
1975-02-01T00:00:00Z